QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2013     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Pazopanib (Paz) monotherapy in Asian women who have not progressed after first-line chemotherapy for advanced ovarian, Fallopian tube, or primary peritoneal carcinoma 会议论文 作者:  Zang, Rongyu;  Wu, Lingying;  Zhu, Jianqing;  Kong, Beihua;  Kim, Byoung-Gie 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19 Pazopanib (Paz) monotherapy in Asian women who have not progressed after first-line chemotherapy for advanced ovarian, Fallopian tube, or primary peritoneal carcinoma 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2013-05-20 作者:  Zang, Rongyu;  Wu, Lingying;  Zhu, Jianqing;  Kong, Beihua;  Kim, Byoung-Gie 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 Pazopanib (Paz) monotherapy in Asian women who have not progressed after first-line chemotherapy for advanced ovarian, Fallopian tube, or primary peritoneal carcinoma 期刊论文 2013, 卷号: 31, 期号: 15 作者:  Zang, Rongyu;  Wu, Lingying;  Zhu, Jianqing;  Kong, Beihua;  Kim, Byoung-Gie 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/13 Pazopanib (Paz) monotherapy in Asian women who have not progressed after first-line chemotherapy for advanced ovarian, Fallopian tube, or primary peritoneal carcinoma 会议论文 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2013 作者:  Zang, Rongyu;  Wu, Lingying;  Zhu, Jianqing;  Kong, Beihua;  Kim, Byoung-Gie 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/31